/Investor DB

Foresite Capital — Full Portfolio

242 tracked investments · page 2 of 2 · listed companies and verified rows first

Site by Goodlabgoodlab.mediain

Goodlab is an innovation design studio that provides brand strategy, storytelling, design, and engineering services for companies in science, health, wellness, and environmental fields.

BiotechCreator EconomyHealthtechMarketing Tech

John Montgomery(Founder)in

Slate Medicinesslatemedicines.cominFeb 2026

Slate Medicines is a clinical-stage biotechnology company.

BiotechMedical DevicesBoston, US

Sara Pacheco(Executive Officer)Neil Buckley(Executive Officer, Director)inGregory Oakes(Chief Executive Officer and Board Director)in

BoardTim Lohoff(Director)Cindy Xiong(Director)inAndrew Levin(Director)

Co-investorsRA CapitalVenrock

Sollis Healthsollishealth.cominSeries B · Dec 2024 · $33M

Sollis Health operates a telehealth and urgent care platform staffed by experienced emergency medicine physicians and clinicians from top hospitals.

Digital HealthHealthtechWellness & FitnessLos Angeles, US

Dr. Scott Braunstein(Chief Medical Officer)

Co-investorsAtento CapitalBlack Jays Venturesblue 9 capitalFriedomTorch CapitalArkitekt Ventures+2 more

SomaLogicsomalogic.comNov 2020 · $121M

SomaLogic develops proteomics tools that help researchers measure protein function and study human biology across a range of scientific applications.

BiotechDeep TechHealthtechBoulder, US

Larry Gold(Director)inLarry Gold PhD(Founder)inDaniel Muehl(Executive Officer)Byron Hewett(Executive Officer, Director)in

BoardCharles Lillis(Director)Youichi Yabuuchi(Director)

Co-investorsKhosla VenturesCasdin CapitalMagnetar CapitalReimagined VenturesSoleus CapitalT. Rowe Price

Stackshinestackshine.comin𝕏SeedAcquired

Stackshine provides software discovery and workflow automation for enterprise IT operations, helping organizations manage employee onboarding and offboarding, reduce software costs, and improve security.

Enterprise SoftwareSaaSPortland, US

Tyler Diaz(Founder)in

Co-investorsY CombinatorGoodFin VenturesRebel Fund

Stepfulstepful.comin𝕏

Stepful provides affordable, online healthcare education programs with live instruction and personalized coaching to train students for healthcare careers.

EdTechHealthtechNew York City, US

Carl Madi(CEO and Co-Founder)inTressia Hobeika(Founder)inEdoardo Serra(Founder)in

Co-investorsAlleyCorpEqual Opportunity VenturesOak HC/FTPioneerReach CapitalSemperVirens Venture Capital+8 more

Structure Therapeuticsstructuretx.comin𝕏

Co-investorsF-Prime CapitalQiming Venture Partners

Tassotassoinc.comin𝕏Dec 2019

Tasso develops diagnostic testing devices and platforms for home use, enabling patients to perform health monitoring and inform clinical decisions outside traditional healthcare settings.

Digital HealthHealthtechMedical DevicesSeattle, US

Ben Casavant(Co-Founder and Chief Executive Officer)inErwin Berthier(Co-Founder and Chief Technology Officer)inAlan Levy(Director)

BoardElizabeth Hambrecht(Director)Paul Conley(Director)in

Co-investorsJ2 VenturesMerck Global Health Innovation FundMSD Global Health Innovation FundOMX VenturesRA CapitalTechstars+3 more

Theseustheseus.usinApr 2021

Theseus builds robotic situational awareness software using visual positioning for drones that operate in GPS-denied environments.

Advanced ManufacturingAI & Machine LearningDefense TechHardwareRoboticsSan Francisco, US

Ian Laffey(Founder)inSacha Lévy(Founder)in

Co-investorsY CombinatorFirst Round CapitalPioneerAntlerEndor CapitalLongitude Capital+6 more

Third Arc Biothirdarcbio.cominJul 2024

Third Arc Bio develops breakthrough treatments in oncology and immunology through advanced biologics engineering.

BiotechMedical DevicesLower Gwynedd, US

Joseph Erhardt(Executive Officer)inPeter Lebowitz(Executive Officer, Director)

BoardArjun Goyal(Director)inOtello Stampacchia(Director)inFrancesco Draetta(Director)in

Co-investorsAndreessen HorowitzVida Venturesabrdn plcBiotechnology Value FundHillhouse InvestmentOmega Funds+1 more

Thymemeetthyme.cominNov 2025 · $97MAcquired

Thyme has partnered with Altruist to create Hazel, an AI product for wealth management professionals.

AI & Machine LearningEnterprise SoftwareFintechSan Francisco, US

Daniel Lantz(Founder)inFernando San Martin(Founder)in

Co-investorsY CombinatorAlleyCorpConcord Health PartnersCVS Health VenturesFrist Cressey VenturesHumana+1 more

Thyme Carethymecare.comin𝕏Sep 2025

Thyme Care develops software to enhance care coordination and outcomes for cancer patients.

Digital HealthHealthtechNashville, US

Robin Shah(Executive Officer, Director)inBobby Green(Founder)in

BoardBrian Belsky(Director)inElizabeth Canis(Director)inBrenton Fargnoli(Director)inVineeta Agarwala(Director)in

Co-investorsAlleyCorpAndreessen HorowitzCorewell Health VenturesCVS Health VenturesEcho Health VenturesFrist Cressey Ventures+5 more

Uniqureuniqure.comin𝕏

uniQure is a biotech company developing gene therapies for serious genetic diseases.

BiotechHealthtechMedical Devices

Matthew Kapustain

Co-investorsAdvent Life SciencesHEALTHCARE ROYALTY PARTNERSRidgeback Capital

VENATORX PHARMACEUTICALS INCvenatorx.com

Developing ceftibuten-ledaborbactam etzadroxil, a clinical phase 3-ready oral beta-lactam/beta-lactamase inhibitor combination for complicated urinary tract infections.

BiotechMalvern, US

Christopher J. Burns(Executive Officer, Director)Daniel C. Pevear(Executive Officer)Michael Diem(Director)Vincent J. Milano(Director)Ezra Felker(Executive Officer)Shelley Chu(Director)

Co-investorsAMR Action FundBioAdvanceVersant Ventures

Verona Pharmaveronapharma.comin

Verona Pharma develops treatments for chronic lung conditions.

BiotechHealthtechLondon

Jan-Anders Karlsson(Executive Officer, Director)inPeter Spargo(Executive Officer)inPatrick Humphrey(Director)Ken Cunningham(Director)Kenneth Newman(Executive Officer)Anders Ullman(Director)

Co-investorsAccess BiotechnologyAisling CapitalAndera PartnersFrazier Life SciencesNew Enterprise Associates (NEA)Sofinnova Partners+4 more

Verve Therapeuticsvervetx.comJan 2021

Cambridge, MA biotech developing single-course in vivo base editing medicines to permanently lower cardiovascular disease risk.

BiotechCambridge, US

Andrew Ashe(Executive Officer)Sekar Kathiresan(Executive Officer, Director)inAndrew Bellinger(Executive Officer)

BoardJohn Evans(Director)Anthony Philippakis(Director)inKrishna Yeshwant(Director)in

Co-investorsARCH Venture PartnersF-Prime CapitalGV (Google Ventures)RA CapitalvenBio PartnersCasdin Capital+3 more

Xaira Therapeuticsxaira.comin𝕏Series A · Apr 2024 · $1B

Xaira develops AI and machine learning tools for drug discovery and protein design, serving pharmaceutical and biotech companies.

AI & Machine LearningBiotechMedical DevicesSouth San Francisco, US

Hetu Kamisetty(Founder)Marc Tessier-Lavigne(Chairman & Chief Executive Officer)inDr. Ci Chu(Chief Discovery Officer)Dr. Bo Wang(Chief AI Scientist)Dr. Ian McCaffery(SVP, Translational Science and Early Clinical Development)

Co-investorsARCH Venture PartnersBreyer CapitalDeviation CapitalF-Prime CapitalLongwood FundMenlo Ventures+2 more

Zenefitszenefits.com𝕏Acquired

Zenefits provides an HR platform that consolidates benefits administration, payroll, onboarding, and talent management tools for small and mid-sized businesses into a single application.

Enterprise SoftwareHR TechSan Francisco, US

Parker Conrad(Co-founder & CEO)inLaks Srini(Founder/CTO)in

Co-investorsAndreessen HorowitzBling CapitalEPIC VENTURESFJ LabsFrancisco PartnersInsight Partners+17 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Sotera WirelessTenSixteen BioTesseract HealthThe Medicines CompanyTP TherapeuticsTurning Point TherapeuticsVeliaVignette BioVitae PharmaceuticalsVoyager Therapeutics (Alumni)Xinthera

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.